JP6258346B2 - 流体流路を通る流体流れの選択的制御 - Google Patents
流体流路を通る流体流れの選択的制御 Download PDFInfo
- Publication number
- JP6258346B2 JP6258346B2 JP2015545174A JP2015545174A JP6258346B2 JP 6258346 B2 JP6258346 B2 JP 6258346B2 JP 2015545174 A JP2015545174 A JP 2015545174A JP 2015545174 A JP2015545174 A JP 2015545174A JP 6258346 B2 JP6258346 B2 JP 6258346B2
- Authority
- JP
- Japan
- Prior art keywords
- fluid
- flow
- flow control
- control valve
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000012530 fluid Substances 0.000 title claims description 540
- 230000008859 change Effects 0.000 claims description 37
- 230000004044 response Effects 0.000 claims description 10
- 229940079593 drug Drugs 0.000 description 43
- 239000003814 drug Substances 0.000 description 43
- 239000000203 mixture Substances 0.000 description 34
- 238000004891 communication Methods 0.000 description 23
- 238000001802 infusion Methods 0.000 description 23
- 238000000034 method Methods 0.000 description 21
- 230000015654 memory Effects 0.000 description 20
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 18
- 238000011144 upstream manufacturing Methods 0.000 description 18
- 238000001990 intravenous administration Methods 0.000 description 15
- 230000007704 transition Effects 0.000 description 15
- 230000003287 optical effect Effects 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 12
- 239000008280 blood Substances 0.000 description 12
- 238000002347 injection Methods 0.000 description 11
- 239000007924 injection Substances 0.000 description 11
- 238000010586 diagram Methods 0.000 description 9
- 230000007246 mechanism Effects 0.000 description 9
- 229960005181 morphine Drugs 0.000 description 9
- 238000004590 computer program Methods 0.000 description 7
- 230000007613 environmental effect Effects 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 6
- 238000004806 packaging method and process Methods 0.000 description 6
- 230000000007 visual effect Effects 0.000 description 6
- 238000012790 confirmation Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 230000005540 biological transmission Effects 0.000 description 4
- 230000008406 drug-drug interaction Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000003339 best practice Methods 0.000 description 3
- 238000002483 medication Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 206010013700 Drug hypersensitivity Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000003759 clinical diagnosis Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000008713 feedback mechanism Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000003978 infusion fluid Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229940037201 oris Drugs 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 238000009428 plumbing Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000001960 triggered effect Effects 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000002473 artificial blood Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000010836 blood and blood product Substances 0.000 description 1
- 229940125691 blood product Drugs 0.000 description 1
- 239000003633 blood substitute Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- BPKIGYQJPYCAOW-FFJTTWKXSA-I calcium;potassium;disodium;(2s)-2-hydroxypropanoate;dichloride;dihydroxide;hydrate Chemical compound O.[OH-].[OH-].[Na+].[Na+].[Cl-].[Cl-].[K+].[Ca+2].C[C@H](O)C([O-])=O BPKIGYQJPYCAOW-FFJTTWKXSA-I 0.000 description 1
- 238000004422 calculation algorithm Methods 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- -1 cryoprecipitate Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 235000020805 dietary restrictions Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 201000005311 drug allergy Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000004023 fresh frozen plasma Substances 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 238000003032 molecular docking Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 238000009512 pharmaceutical packaging Methods 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
Description
ここで、t1=注入流体212が一次配管セグメント202に入る時間とすると、
t1=体積/流量=(V2+V3)/R2=(1mL+3mL)/60mL/分=4mL/60mL/分
t1=1/15分=4秒
ここで、t2=注入流体212が患者貫通セグメント204に流入するための時間とすると、
t2=V3/R1=3mL/(60mL/時間)=3mL/1mL/分=3分
すべての流体212が患者に到達するための時間tx=t1+t2=4秒+3分=184秒となる。
Claims (4)
- 流体ポートを備えたシステムであって、
該流体ポートが、
流体チャネルと、
手動投与可能な流体供給源の出口に連結するように構成された、前記流体チャネルの第1の端部にある流体入口と、
流体を、前記手動投与可能な流体供給源から前記流体を患者に提供する流体流路に送達するように構成された、前記流体チャネルの第2の端部にある流体出口と、
前記手動投与可能な流体供給源からの前記流体の少なくとも1つの属性を判定するように構成された少なくとも1つのセンサであって、前記流体入口の下流側の前記流体であって前記流体流路を通る流体流れが抑止された後、依然として前記流体チャネル内にある前記流体の、抜き取られた下流側流体体積を自動的に測定するように構成されている少なくとも1つのセンサと、
前記少なくとも1つのセンサと通信し、少なくとも1つのルールによって指定された少なくとも1つの条件に整合する前記判定された少なくとも1つの属性に応答して、少なくとも1つの動作変更信号を生成する制御装置と、
前記動作変更信号を少なくとも1つの装置にワイヤレスで送信し、前記動作変更信号は前記少なくとも1つの装置によって受信された場合、前記少なくとも1つの装置に少なくとも1つの動作パラメータを変更させる送信機と
を備えることを特徴とするシステム。 - 前記少なくとも1つの装置は、流量制御弁を備え、前記動作変更信号は、前記流量制御弁を通る流体の流体流れ制限のレベルを変更させることを特徴とする請求項1に記載のシステム。
- 前記少なくとも1つの装置は、医療装置を備えることを特徴とする請求項1に記載のシステム。
- 前記医療装置は、前記流体流路を通る流体流れが制限されるようにすることを特徴とする請求項3に記載のシステム。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261731469P | 2012-11-29 | 2012-11-29 | |
US61/731,469 | 2012-11-29 | ||
PCT/US2013/071891 WO2014085395A1 (en) | 2012-11-29 | 2013-11-26 | Selectively controlling fluid flow through a fluid pathway |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017234422A Division JP6659657B2 (ja) | 2012-11-29 | 2017-12-06 | 流体流路を通る流体流れの選択的制御 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2016504072A JP2016504072A (ja) | 2016-02-12 |
JP6258346B2 true JP6258346B2 (ja) | 2018-01-10 |
Family
ID=49880957
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015545174A Active JP6258346B2 (ja) | 2012-11-29 | 2013-11-26 | 流体流路を通る流体流れの選択的制御 |
JP2017234422A Active JP6659657B2 (ja) | 2012-11-29 | 2017-12-06 | 流体流路を通る流体流れの選択的制御 |
JP2020019105A Active JP6940637B2 (ja) | 2012-11-29 | 2020-02-06 | 流体流路を通る流体流れの選択的制御 |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017234422A Active JP6659657B2 (ja) | 2012-11-29 | 2017-12-06 | 流体流路を通る流体流れの選択的制御 |
JP2020019105A Active JP6940637B2 (ja) | 2012-11-29 | 2020-02-06 | 流体流路を通る流体流れの選択的制御 |
Country Status (11)
Country | Link |
---|---|
EP (2) | EP2925387B1 (ja) |
JP (3) | JP6258346B2 (ja) |
KR (1) | KR101835864B1 (ja) |
CN (2) | CN109125855B (ja) |
AU (4) | AU2013352393B2 (ja) |
BR (1) | BR112015012658A2 (ja) |
CA (1) | CA2892758C (ja) |
ES (2) | ES2652270T3 (ja) |
MX (1) | MX362559B (ja) |
SG (1) | SG11201504165QA (ja) |
WO (1) | WO2014085395A1 (ja) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3341045B1 (en) * | 2015-08-28 | 2020-12-30 | Crisi Medical Systems, Inc. | Flow sensor system with connection assembly |
ES2781205T3 (es) * | 2015-08-28 | 2020-08-31 | Crisi Medical Systems Inc | Sistema de sensor de flujo que incluye conexión transmisiva |
EP3673936B1 (en) | 2015-08-28 | 2023-10-11 | Crisi Medical Systems, Inc. | Flow sensor system including spring contacts |
WO2017089615A1 (en) | 2015-11-27 | 2017-06-01 | Jean-Pierre Peters | Infusion system |
CN113908374B (zh) * | 2016-06-17 | 2023-11-28 | 贝克顿·迪金森公司 | 用于润湿流体端口的内部流体路径表面以增进超声信号传输的方法和设备 |
WO2018236638A1 (en) | 2017-06-19 | 2018-12-27 | Becton, Dickinson And Company | PRIMING VALVE TO INDUCE PROPER PRESSURE AND FLOW PROFILE AND ENHANCE SENSOR AVAILABILITY |
US11751939B2 (en) | 2018-01-26 | 2023-09-12 | Axon Therapies, Inc. | Methods and devices for endovascular ablation of a splanchnic nerve |
CA3159565A1 (en) * | 2019-11-08 | 2021-05-14 | Bio Health Frontiers, Inc. | Differential pressure fluid delivery system |
AU2021208701A1 (en) * | 2020-01-17 | 2022-07-07 | Axon Therapies, Inc. | Methods and devices for endovascular ablation of a splanchnic nerve |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6241704B1 (en) * | 1901-11-22 | 2001-06-05 | Sims Deltec, Inc. | Drug pump systems and methods |
DE4137837C1 (ja) * | 1991-11-18 | 1992-10-29 | Fresenius Ag, 6380 Bad Homburg, De | |
CN2326263Y (zh) * | 1998-06-05 | 1999-06-30 | 陈肯 | 智能输液监控仪 |
US6685668B1 (en) * | 2000-07-31 | 2004-02-03 | Abbott Laboratories | Closed-loop IV fluid flow control |
EP2284743A3 (en) * | 2003-03-28 | 2013-08-14 | CareFusion 303, Inc. | Infusion data communication system |
US7361155B2 (en) * | 2003-09-16 | 2008-04-22 | Therafuse, Inc. | Compensating liquid delivery system and method |
US7029456B2 (en) * | 2003-10-15 | 2006-04-18 | Baxter International Inc. | Medical fluid therapy flow balancing and synchronization system |
WO2006046242A2 (en) * | 2004-10-26 | 2006-05-04 | Pro-Iv Ltd. | Apparatus, system and method for administration of a substance |
EP1944709A1 (en) * | 2005-02-11 | 2008-07-16 | Cardinal Health 303 Inc. | Identification system and method for medication management |
US7991627B2 (en) * | 2005-06-21 | 2011-08-02 | General Electric Company | Injected drug identification and fail-safe system |
CN2808160Y (zh) * | 2005-07-06 | 2006-08-23 | 重庆邮电学院 | 输液监控器 |
WO2007033025A2 (en) * | 2005-09-12 | 2007-03-22 | Ethicon Endo-Surgery, Inc. | Apparatus and methods for controlling and automating fluid infusion activities |
US7981073B2 (en) * | 2006-03-30 | 2011-07-19 | Moellstam Anders | Method and device for irrigation of body cavities |
EP2121080B1 (en) * | 2007-02-26 | 2017-11-01 | CareFusion 303, Inc. | Automatic relay pump system |
EP2135630B1 (en) * | 2007-04-09 | 2014-05-07 | Obshchestvo S Ogranichennoy Otvetstvennostiu "Nauchno Proizvodstvennaya Firma 'Pozitom-Pro'" | Automated strontium-rubidium infusion system |
CN100506300C (zh) * | 2007-06-25 | 2009-07-01 | 李斌 | 便携式输液监控器 |
EP2197350A2 (en) * | 2007-09-11 | 2010-06-23 | Baxter International Inc. | Infusion therapy sensor system |
CA2701464A1 (en) * | 2007-10-04 | 2009-04-09 | Baxter International Inc. | Apparatus for a fluid delivery system with controlled fluid flow rate |
US8394053B2 (en) | 2009-11-06 | 2013-03-12 | Crisi Medical Systems, Inc. | Medication injection site and data collection system |
CN101732778B (zh) * | 2009-11-19 | 2012-07-25 | 重庆理工大学 | 输液监控智能系统 |
WO2011126485A1 (en) * | 2010-04-08 | 2011-10-13 | Cardiac Protection Solutions, Llc | Method and apparatus for delivering continuous intravenous infusion of metoprolol |
US20110251584A1 (en) * | 2010-04-08 | 2011-10-13 | Umesh Khot | Method and apparatus for delivering continuous intravenous infusion of metoprolol |
US8287486B2 (en) * | 2010-05-25 | 2012-10-16 | Alcon Research, Ltd. | Infusion pressure monitoring system |
JP2012066004A (ja) * | 2010-09-27 | 2012-04-05 | Ricoh Co Ltd | 送液システム、送液方法及びプログラム |
WO2012126744A1 (en) * | 2011-03-18 | 2012-09-27 | Gambro Lundia Ab | Infusion system and method of integrity testing and leak detection |
MX349809B (es) * | 2011-12-21 | 2017-08-11 | Deka Products Lp | Sistema de bomba y método para estimar acústicamente el suministro de líquido. |
-
2013
- 2013-11-26 JP JP2015545174A patent/JP6258346B2/ja active Active
- 2013-11-26 ES ES13812252.8T patent/ES2652270T3/es active Active
- 2013-11-26 EP EP13812252.8A patent/EP2925387B1/en active Active
- 2013-11-26 CA CA2892758A patent/CA2892758C/en active Active
- 2013-11-26 ES ES17189171T patent/ES2839425T3/es active Active
- 2013-11-26 CN CN201811024491.8A patent/CN109125855B/zh active Active
- 2013-11-26 EP EP17189171.6A patent/EP3278825B1/en active Active
- 2013-11-26 CN CN201380068994.4A patent/CN104918643B/zh active Active
- 2013-11-26 BR BR112015012658A patent/BR112015012658A2/pt not_active Application Discontinuation
- 2013-11-26 WO PCT/US2013/071891 patent/WO2014085395A1/en active Application Filing
- 2013-11-26 KR KR1020157017211A patent/KR101835864B1/ko active IP Right Grant
- 2013-11-26 AU AU2013352393A patent/AU2013352393B2/en active Active
- 2013-11-26 MX MX2015006504A patent/MX362559B/es active IP Right Grant
- 2013-11-26 SG SG11201504165QA patent/SG11201504165QA/en unknown
-
2017
- 2017-04-28 AU AU2017202841A patent/AU2017202841B2/en active Active
- 2017-12-06 JP JP2017234422A patent/JP6659657B2/ja active Active
-
2019
- 2019-09-05 AU AU2019226203A patent/AU2019226203B2/en active Active
-
2020
- 2020-02-06 JP JP2020019105A patent/JP6940637B2/ja active Active
- 2020-09-28 AU AU2020244396A patent/AU2020244396B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11464904B2 (en) | Selectively controlling fluid flow through a fluid pathway | |
JP6940637B2 (ja) | 流体流路を通る流体流れの選択的制御 | |
US10293107B2 (en) | Selectively Controlling fluid flow through a fluid pathway | |
AU2004226440B2 (en) | Method and apparatus to prevent medication error in a networked infusion system | |
JP2024509918A (ja) | 輸液管理システム |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20160630 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160712 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20161011 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170404 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20170704 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170720 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20171010 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20171108 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20171206 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6258346 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |